​

Xenon Pharmaceuticals Ownership | Who Owns Xenon Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Xenon Pharmaceuticals Ownership Summary

Xenon Pharmaceuticals is owned by 39.13% institutional investors, 0.11% insiders, and 60.76% retail investors. Fmr is the largest institutional shareholder, holding 11.30% of XENE shares. American Funds SMALLCAP World A is the top mutual fund, with 5.07% of its assets in Xenon Pharmaceuticals shares.

XENE Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockXenon Pharmaceuticals39.13%0.11%60.76%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr8.92M11.30%$358.09M
Avoro capital advisors5.40M6.84%$216.81M
Blackrock funding, inc. /de5.10M6.44%$228.59M
Driehaus capital management4.17M5.28%$167.39M
Wellington management group llp3.61M4.57%$144.94M
Braidwell lp3.61M4.57%$144.74M
Capital investors3.41M4.31%$153.06M
Janus henderson group2.87M3.68%$112.43M
Commodore capital lp2.70M3.42%$108.41M
Polar capital2.55M3.23%$102.25M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Commodore capital lp2.70M5.29%$108.41M
Affinity asset advisors1.40M4.90%$56.21M
First turn management799.74K4.82%$32.11M
Saturn v capital management503.70K4.44%$20.22M
Braidwell lp3.61M4.29%$144.74M
Foresite capital management iv160.00K3.52%$6.42M
Tri locum partners lp366.10K3.38%$14.70M
Great point partners200.00K3.31%$8.03M
Bioimpact capital503.40K3.31%$20.21M
Altium capital management lp288.00K3.20%$11.29M

Top Buyers

HolderShares% AssetsChange
Wellington management group llp3.61M0.03%1.44M
T. rowe price investment management599.11K0.01%522.17K
Barclays600.96K0.01%489.66K
Caligan partners lp444.56K2.34%444.56K
Federated hermes672.24K0.05%439.74K

Top Sellers

HolderShares% AssetsChange
Paradigm biocapital advisors lp---2.04M
Samlyn capital---1.02M
Vestal point capital, lp1.10M1.99%-900.00K
Pictet asset management sa625.99K0.03%-636.59K
Orbimed advisors419.60K0.40%-528.28K

New Positions

HolderShares% AssetsChangeValue
Caligan partners lp444.56K2.34%444.56K$17.85M
Tri locum partners lp366.10K3.38%366.10K$14.70M
Jain global252.38K0.05%252.38K$10.13M
Axa investment managers176.16K0.02%176.16K$7.07M
Peregrine capital management174.85K0.24%174.85K$7.84M

Sold Out

HolderChange
Twin peaks wealth advisors-1.00
Tortoise investment management-2.00
Dinuzzo private wealth-2.00
Sjs investment consulting-5.00
American national bank-5.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2025150-34.78%31,012,004-63.22%390.34%73-31.13%49-30.00%
Sep 30, 2025142-30.39%50,518,761-37.12%630.61%62-45.13%48-12.73%
Jun 30, 20252110.48%83,114,83911.81%1051.18%11626.09%57-18.57%
Mar 31, 2025213-76,727,6550.58%971.02%92-3.16%725.88%
Dec 31, 2024117-43.75%35,698,172-52.33%450.50%51-43.33%38-38.71%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
American Funds SMALLCAP World A4.05M5.07%227.47K
Vanguard Health Care Inv3.34M4.18%863.22K
Strategic Advisers Fidelity US TtlStk2.02M2.52%-
iShares Russell 2000 ETF1.83M2.28%1.83M
Polar Capital Biotech S Inc1.43M1.78%-
Fidelity Select Health Care1.29M1.61%3.50K
Polar Capital Healthcare Opports Inc907.51K1.13%-
Fidelity Small Cap Index767.38K0.96%4.22K
Fidelity Advisor Biotechnology I710.76K0.89%-
Pictet Biotech658.54K0.87%658.54K

Recent Insider Transactions

DateNameRoleActivityValue
Mar 10, 2026KENNEY CHRISTOPHER JOHN Chief Medical OfficerSell$166.56K
Mar 10, 2026DiFabio Andrea Chief Legal OfficerSell$156.70K
Mar 09, 2026MORTIMER IAN PRESIDENT & CEOSell$1.28M
Mar 09, 2026MORTIMER IAN PRESIDENT & CEOSell$2.57M
Mar 09, 2026MORTIMER IAN PRESIDENT & CEOSell$1.90M

Insider Transactions Trends

DateBuySell
2026 Q1-14
2025 Q4-5
2025 Q2-1
2025 Q1-4
2024 Q4-4

XENE Ownership FAQ

Who Owns Xenon Pharmaceuticals?

Xenon Pharmaceuticals shareholders are primarily institutional investors at 39.13%, followed by 0.11% insiders and 60.76% retail investors. The average institutional ownership in Xenon Pharmaceuticals's industry, Biotech Stocks , is 381.47%, which Xenon Pharmaceuticals falls below.

Who owns the most shares of Xenon Pharmaceuticals?

Xenon Pharmaceuticals’s largest shareholders are Fmr (8.92M shares, 11.30%), Avoro capital advisors (5.4M shares, 6.84%), and Blackrock funding, inc. /de (5.1M shares, 6.44%). Together, they hold 24.57% of Xenon Pharmaceuticals’s total shares outstanding.

Does Blackrock own Xenon Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Xenon Pharmaceuticals.

Who is Xenon Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Commodore capital lp is Xenon Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 5.29% of its assets in 2.7M Xenon Pharmaceuticals shares, valued at 108.4M$.

Who is the top mutual fund holder of Xenon Pharmaceuticals shares?

American Funds SMALLCAP World A is the top mutual fund holder of Xenon Pharmaceuticals shares, with 5.07% of its total shares outstanding invested in 4.05M Xenon Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools